Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Investing

First patient dosed in Phase IIb imaging for Brain Mets

by admin April 28, 2025
April 28, 2025
First patient dosed in Phase IIb imaging for Brain Mets

Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets

Download the PDF here.

This post appeared first on investingnews.com

previous post
Silver Crown Royalties Announces Closing of Final Tranche of its Non-Brokered Private Placement
next post
Greenland’s prime minister says island cannot be bought, US has ‘not been respectful’

Related Posts

Top 5 Canadian Mining Stocks This Week: San...

March 8, 2025

White Cliff Minerals Limited (ASX: WCN) – Trading...

May 5, 2025

Crypto Market Recap: Bitcoin Price Hits New All-time...

May 22, 2025

Group Eleven Closes $2.5m Private Placement

March 1, 2025

Experts: Battery and Precious Metals Emerging as New...

February 24, 2025

Investment Protection Agreement with the Ecuador Government on...

May 28, 2025

AngloGold Completes Tropicana Renewables Project

April 3, 2025

Crypto Market Recap: Circle, Klarna and Chime May...

April 5, 2025

Altech – Agreement to Secure EUR2.5M in Funding

March 25, 2025

CONNEQT Launches Apple Health Integration on iPhone

April 1, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 4

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 5

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 6

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 wallstreetwizardry.com | All Rights Reserved